.jpg?w=2580&hash=D5ACF3C857A94A4861D1166122105731)
ENDO 2025 will take place July 12-15, 2025, in San Francisco, CA. We are excited to announce new and updated topics for ENDO 2025 abstract submissions! Our revised topics reflect insight on latest trends, challenges, and innovations in the field of Endocrinology. We invite you to contribute your insights and research.
Please read the following Abstract Submission Instructions prior to submitting your abstract. If you have any questions not answered within this webpage, please email [email protected].
Abstracts will not be accepted for this submission period beyond the stated deadline, Thursday, January 30, 2025, at 1:00 PM ET US. Late-breaking abstracts will be accepted April 15 – May 6 2025.
Language editing, translation, and poster formatting services are available through American Journal Experts. Endocrine Society members receive an additional 10% off. Visit aje.com/go/esmeetings for more information.
A non-refundable fee of $99.00 USD is due at the time of abstract submission. (Major credit cards are accepted).
Membership is not a requirement to submit an abstract for ENDO, but Endocrine Society members receive special discounted ENDO registration rates. You must be an Endocrine Society member to be considered for abstract awards. Join Now to get the best rate for ENDO.
You will be prompted to complete the following steps when submitting an abstract:
If you are unable to finish your abstract submission in one sitting, you must at least complete Step 1: Abstract Title, in order to have your submission saved and be able to return to the abstract submission site to complete any time prior to the deadline. All abstracts must be completed and submitted by the abstract submission deadline of Thursday, January 30, 2025 at 1:00 PM ET US. If you do not complete the submission prior to the deadline, your abstract will not be considered.
Abstract titles should be short and specific, and entered in title case (the first letter of each word is capitalized, except for certain small words, such as articles, conjunctions, and prepositions).
For assistance with putting your abstract title in title case, visit www.capitalizemytitle.com
Example:
This Is a Properly Formatted Title
You may select your abstract to be considered for an Oral Presentation, Rapid Fire Poster Presentation, or a Traditional Poster Presentation. Please Note: Authors of accepted abstracts will receive further information and technical guidelines on how to prepare for their oral, rapid fire, or poster presentation.
The highest-ranked abstracts are selected for Oral Session Presentations. These sessions will take place in San Francisco, CA on July 12-15, 2025. Presenting authors will have dedicated time to give a 10-minute presentation using slides to summarize their abstract followed by a brief 3-5 minute question and answer session. Note: Abstracts not accepted for an Oral Presentation will automatically be considered for Rapid Fire and/or Poster Presentations. Abstracts selected for an Oral Presentation will not present a physical poster.
Rapid Fire Poster Presentations will take place in San Francisco, CA on July 12-15, 2025. Presenting authors will give a 2-5-minute presentation with no more than 5 slides, highlighting the key points, so interested attendees can ask questions about your work in the subsequent communications. Select this option if you do not wish to be considered for an oral presentation and want to provide a quick synopsis of your work. The Rapid Fire Poster Presentations will be delivered in session rooms prior to oral abstract presentations. Additionally, abstracts selected for Rapid Fire Poster Presentations will also present a traditional printed poster in the poster all (see additional details in the section below)
Poster Presentations will take place in-person in San Francisco, CA from Saturday July 12, 2025 to Monday July 14, 2025. Presenting authors will be able to display a traditional poster on an expansive poster floor. Poster presenters will be assigned one day to display their printed poster at the conference. In addition, poster presenters will be able to stand next to their printed poster during a Meet-and-Greet session. Presenting authors will bring their poster to be presented in the exhibit hall and receive comments and questions on their poster(s) from meeting participants. Select this option if you do not wish to be considered for an oral or rapid-fire presentation and want to take advantage of presenting your work in the poster hall.
Basic, clinical, translational scientific abstracts, clinical case reports, and clinical trials are accepted for submission across over 100 topical areas. Navigate to the right to view the complete list.
Navigate to the right for detailed information on submitting abstracts.
Edits to authors will not be accepted after the posted date. Please review this information carefully to ensure you have included all authors. You may also change the presenting author here at any time up until the abstract submission site closes (NOTE: There can be only one Presenting Author in your submission).
Enter contact information and disclosures for the presenting author. Based on the disclosures entered for the presenting author, complete the Conflict of Interest (COI) resolution and recording permissions. If you change the presenting authors, you must also update the COI and permissions pertinent to the new presenting author. Up to 35 authors are allowed on each abstract.
In accordance with requirements of the Accreditation Council for Continuing Medical Education (ACCME), the Endocrine Society requires all individuals who are in a position to control the content of a CME activity to disclose all financial relationships with any commercial interest that produces, markets, resells, or distributes healthcare goods or services consumed by or used on patients.
Financial relationships are defined as remuneration paid to you in any amount that has occurred within the last 24 months when these two conditions apply:
If a potential conflict of interest exists as a result of a financial relationship, this will need to be resolved prior to the activity. All financial relationships must be disclosed to learners at the beginning of the CME activity. If no financial relationships exist, learners must be informed of that as well.
If you listed a conflict of interest for your abstract presentation when you completed your disclosures and a potential conflict exists as a result of a financial relationship, this will need to be resolved prior to the activity. Please complete this step to assist with resolving any potential conflict of interests so that the Endocrine Society may provide CME on your presentation.
The Endocrine Society will record oral abstract presentations and rapid fire presentations, with your consent, and will make the recording available through Endocrine Society distribution channels. In this section, please select your options and provide requested information.
IMPORTANT: Please carefully review your abstract and author information before finalizing your submission. Presenting authors may edit their abstract by returning to the abstract submission site at any time prior to the submission deadline. No edits can be made once the submission site closes. Accepted abstracts will be published online in the ENDO program, in the ENDO mobile app, and in the Journal of the Endocrine Society (JES). Authors will not have an opportunity to review or approve proofs of their abstract before it appears online and in JES, and corrections after publication in JES are not possible.
The Endocrine Society provides awards to recognize outstanding work in endocrinology. These recognition awards are given to outstanding abstracts submitted by in-training fellows and new faculty whom who have been accepted to present their research during the annual meeting (ENDO). Please visit endocrine.org/awards for award criteria and more information.
Each award will have varying criteria. Please visit ENDO Awards to learn more. Winner selection for all awards is based on award criteria and abstract score.
Standard Award Requirements:
The ENDO 2025 abstract fee is $99 (USD) per abstract. Abstract fees are non-refundable. Visa, Master Card, and American Express are accepted. Note: Paying the abstract submission fee does not register you for ENDO 2025. All abstract presenters must register to attend ENDO 2025. Please visit endocrine.org/endo2025 for registration information.
If you are having difficulty finalizing your payment, please contact [email protected] or call +1 (217) 398-1792.
Please carefully review your abstract and author information before the abstract submission site closes. No edits can be made once the submission site closes. Accepted abstracts will be published online in the ENDO program, in the ENDO mobile app, and in the Journal of the Endocrine Society (JES). Authors will not have an opportunity to review or approve proofs of their abstract before it appears online and in JES, and corrections after publication in JES are not possible.
You will receive an email confirming your submission. Return to the submission site at any time before the submission deadline to make edits to your abstract. All abstracts must be completed and submitted by the abstract submission deadline, Thursday, January 30 2025 at 1:00 PM ET US. If you do not complete the submission prior to the deadline, your abstract will not be reviewed.
Please make all changes before the abstract submission site closes. No edits can be made to your abstract after the submission site closes.
Submitting (contact) authors may use the link provided through their submission confirmation email to edit their abstract up until the abstract submission deadline. NO REVISIONS to the abstract or the list of authors will be allowed once the site closes on the deadline date.
Abstracts may be withdrawn by sending an email to [email protected]. Withdrawal requests must be submitted by the submitting (contact) author and include the abstract submission confirmation number. The $99 abstract submission fee is not refundable.
Abstract notifications will be emailed to presenting authors only in late-March.
Authors of accepted abstracts will receive presentation details, information and technical guidelines on how to prepare for their oral, rapid-fire, or poster presentation. Presenting authors will not be allowed to reschedule their presentation except for religious reasons (as identified in Step 7 of the submission process).
All accepted abstracts from registered presenters will be published on the meeting website and in a supplemental issue of the Open Access Journal of the Endocrine Society (JES) and assigned a DOI.
